Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
73.7M
-
Shares change
-
+3.47M
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
+$70.8M
-
Put/Call ratio
-
0.22
-
Number of buys
-
76
-
Number of sells
-
-46
-
Price
-
$14.92
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q3 2022
146 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q3 2022.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.7M shares
of 160M outstanding shares and own 45.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.6M shares), COMMODORE CAPITAL LP (4.32M shares), VR Adviser, LLC (4.04M shares), RA CAPITAL MANAGEMENT, L.P. (4.01M shares), TCG Crossover Management, LLC (3.48M shares), STATE STREET CORP (3.41M shares), PERCEPTIVE ADVISORS LLC (3.21M shares), VANGUARD GROUP INC (3.18M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.97M shares), and EVENTIDE ASSET MANAGEMENT, LLC (2.86M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.